Orthofix Medical (OFIX) Restructuring Costs (2023 - 2024)
Orthofix Medical (OFIX) posted Restructuring Costs of $1.3 million for Q4 2024, up 160.4% on a QoQ basis from $505000.0 in Q3 2024, and up 30.72% year-over-year from $1.0 million in Q1 2024.
Orthofix Medical (OFIX) Restructuring Costs (2023 - 2024) Analysis & Trends
Orthofix Medical's Restructuring Costs history runs 2 years deep, the most recent figure standing at $1.3 million for Q4 2024.
- Quarterly Restructuring Costs rose 30.72% year-over-year to $1.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $9.4 million (down 51.61% YoY) and the FY2024 annual result came in at $9.4 million, up 697.28% from the prior year.
- Restructuring Costs was $1.3 million for Q4 2024 at Orthofix Medical, up from $505000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $18.2 million in Q1 2023 and bottomed at -$92000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | Orthofix Medical | 476.50 Mn | 355.63 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | -92,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Mar 31, 2023 | 18.20 Mn |